Seattle Treatment Education Project (STEP) Perspective, Vol. 5, No. 2 - July 1993 * 127 Broadway E. Ste 200 Seattle, WA 98102
Joel Gibson M.S; Laury McKean, RN, BSN
The studies presented below are divided into the following categories:
Monotherapy with nucleoside analogues: single agent treatment with AZT or ddI or ddC.
Nucleoside analogues in combination: two or more agents in combination, AZT/ddi/ddc.
Other antivirals as monotherapy or in combination: single agents which are not nucleoside analogues or combination studies with nucleosides and non- nucleosides.
Immunotherapeutics: agents which specifically target the immune system, and not the virus.
Pathogenesis and long term survival: the natural history of HIV infection, methods of how HIV is thought to cause disease and theories on how to stop progression, and factors associated with long term survival.
Opportunistic infections and other manifestations of HIV disease.
9307
STEP5201
Copyright © 1993 - Seattle Treatment Education Project (STEP) - All rights reserved. Noncommercial reproduction is encouraged. STEP is published four times a year by the Seattle Treatment Education Project, 127 Broadway East, 3rd Floor, Seattle, WA 98102. Email: step100@aol.com STEP web page